Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115851) titled 'Assessing the Cardiorenal Protective Effects of Finerenone in Combination with SGLT2 Inhibitors in Patients with Heart Failure' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai General Hospital
Condition:
heart failure
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-31
Target Sample Size: Combination therapy group vs monotherapy group:900;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303410
Disclaimer: Curated by HT Syndication....